This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Robert T. Wang, MD; David E. Aftergood, MD; Harold E. Carlson, MD

Arch Intern Med. 1985;145(1):143-144.

Abstract
• The neuroleptic malignant syndrome (NMS) developed in a 32-year-old man following fluphenazine enanthate administration. Hypercalcemia was initially present, perhaps reflecting release of calcium from skeletal muscle stores. The elevated serum calcium levels support the existence of a peripheral muscle abnormality in the pathogenesis of the NMS and provides another point of similarity between NMS and malignant hyperthermia.

(Arch Intern Med 1985;145:143-144)

Author Affiliations
From the Medical and Research Services, Veterans Administration Wadsworth Medical Center; and the Department of Medicine, UCLA School of Medicine, Los Angeles. Dr Carlson is now with the Harry S Truman Memorial Veterans Hospital, Columbia, Mo.

Footnotes
Accepted for publication Feb 29, 1984.

Reprint requests to the Endocrinology Section, Harry S Truman Memorial Veterans Hospital, 800 Hospital Dr, Columbia, Mo 65201 (Dr Carlson).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Risk Factors for Neuroleptic Malignant Syndrome: A Case-Control Study
Keck et al.
Arch Gen Psychiatry 1989;46:914-918.
ABSTRACT